Annual CFF
$638.00 K
-$127.22 M-99.50%
December 31, 2023
Summary
- As of February 8, 2025, KZR annual cash flow from financing activities is $638.00 thousand, with the most recent change of -$127.22 million (-99.50%) on December 31, 2023.
- During the last 3 years, KZR annual CFF has fallen by -$99.00 million (-99.36%).
- KZR annual CFF is now -99.50% below its all-time high of $127.86 million, reached on December 31, 2022.
Performance
KZR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$56.00 K-100.00%
September 30, 2024
Summary
- As of February 8, 2025, KZR quarterly cash flow from financing activities is $0.00, with the most recent change of -$56.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, KZR quarterly CFF has stayed the same.
- KZR quarterly CFF is now -100.00% below its all-time high of $99.36 million, reached on December 31, 2021.
Performance
KZR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$115.00 K
-$43.00 K-27.22%
September 30, 2024
Summary
- As of February 8, 2025, KZR TTM cash flow from financing activities is $115.00 thousand, with the most recent change of -$43.00 thousand (-27.22%) on September 30, 2024.
- Over the past year, KZR TTM CFF has stayed the same.
- KZR TTM CFF is now -99.95% below its all-time high of $228.74 million, reached on June 30, 2022.
Performance
KZR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KZR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.5% | 0.0% | 0.0% |
| 3 y3 years | -99.4% | 0.0% | 0.0% |
| 5 y5 years | -99.2% | 0.0% | 0.0% |
KZR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | at low | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -99.5% | +134.6% | -100.0% | at low | -100.0% | at low |
| alltime | all time | -99.5% | +1672.2% | -100.0% | +100.0% | -100.0% | +112.8% |
Kezar Life Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $115.00 K(-27.2%) |
| Jun 2024 | - | $56.00 K(>+9900.0%) | $158.00 K(-67.4%) |
| Mar 2024 | - | $0.00(-100.0%) | $484.00 K(-24.1%) |
| Dec 2023 | $638.00 K(-99.5%) | $59.00 K(+37.2%) | $638.00 K(-41.2%) |
| Sep 2023 | - | $43.00 K(-88.7%) | $1.08 M(-11.6%) |
| Jun 2023 | - | $382.00 K(+148.1%) | $1.23 M(-98.5%) |
| Mar 2023 | - | $154.00 K(-69.6%) | $79.17 M(-38.1%) |
| Dec 2022 | $127.86 M(+13.6%) | $506.00 K(+173.5%) | $127.86 M(-43.6%) |
| Sep 2022 | - | $185.00 K(-99.8%) | $226.71 M(-0.9%) |
| Jun 2022 | - | $78.32 M(+60.3%) | $228.74 M(+51.8%) |
| Mar 2022 | - | $48.85 M(-50.8%) | $150.70 M(+33.9%) |
| Dec 2021 | $112.58 M(+13.0%) | $99.36 M(+4391.7%) | $112.58 M(+731.1%) |
| Sep 2021 | - | $2.21 M(+684.4%) | $13.55 M(+1.9%) |
| Jun 2021 | - | $282.00 K(-97.4%) | $13.30 M(-76.7%) |
| Mar 2021 | - | $10.73 M(+3286.4%) | $57.01 M(-42.8%) |
| Dec 2020 | $99.64 M | $317.00 K(-83.8%) | $99.64 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $1.96 M(-95.5%) | $99.41 M(+2.0%) |
| Jun 2020 | - | $43.99 M(-17.6%) | $97.45 M(+81.7%) |
| Mar 2020 | - | $53.37 M(>+9900.0%) | $53.64 M(>+9900.0%) |
| Dec 2019 | $272.00 K(-99.7%) | $80.00 K(+900.0%) | $272.00 K(+38.1%) |
| Sep 2019 | - | $8000.00(-95.6%) | $197.00 K(-121.9%) |
| Jun 2019 | - | $180.00 K(+4400.0%) | -$898.00 K(-101.2%) |
| Mar 2019 | - | $4000.00(-20.0%) | $77.89 M(-0.0%) |
| Dec 2018 | $77.91 M(+56.6%) | $5000.00(-100.5%) | $77.91 M(+0.0%) |
| Sep 2018 | - | -$1.09 M(-101.4%) | $77.91 M(-9.8%) |
| Jun 2018 | - | $78.97 M(>+9900.0%) | $86.34 M(+73.4%) |
| Mar 2018 | - | $25.00 K(>+9900.0%) | $49.78 M(+0.1%) |
| Dec 2017 | $49.76 M(>+9900.0%) | $0.00(-100.0%) | $49.76 M(0.0%) |
| Sep 2017 | - | $7.34 M(-82.7%) | $49.76 M(+17.3%) |
| Jun 2017 | - | $42.41 M(>+9900.0%) | $42.41 M(>+9900.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | $36.00 K | - | - |
FAQ
- What is Kezar Life Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for Kezar Life Sciences?
- What is Kezar Life Sciences annual CFF year-on-year change?
- What is Kezar Life Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kezar Life Sciences?
- What is Kezar Life Sciences quarterly CFF year-on-year change?
- What is Kezar Life Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kezar Life Sciences?
- What is Kezar Life Sciences TTM CFF year-on-year change?
What is Kezar Life Sciences annual cash flow from financing activities?
The current annual CFF of KZR is $638.00 K
What is the all time high annual CFF for Kezar Life Sciences?
Kezar Life Sciences all-time high annual cash flow from financing activities is $127.86 M
What is Kezar Life Sciences annual CFF year-on-year change?
Over the past year, KZR annual cash flow from financing activities has changed by -$127.22 M (-99.50%)
What is Kezar Life Sciences quarterly cash flow from financing activities?
The current quarterly CFF of KZR is $0.00
What is the all time high quarterly CFF for Kezar Life Sciences?
Kezar Life Sciences all-time high quarterly cash flow from financing activities is $99.36 M
What is Kezar Life Sciences quarterly CFF year-on-year change?
Over the past year, KZR quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Kezar Life Sciences TTM cash flow from financing activities?
The current TTM CFF of KZR is $115.00 K
What is the all time high TTM CFF for Kezar Life Sciences?
Kezar Life Sciences all-time high TTM cash flow from financing activities is $228.74 M
What is Kezar Life Sciences TTM CFF year-on-year change?
Over the past year, KZR TTM cash flow from financing activities has changed by $0.00 (0.00%)